Recombinant Vaccinia virus Protein A33 (A33R), partial

Explore the viral mechanisms with our Recombinant Vaccinia virus A33R (OPG161). This product features Protein OPG161, a significant protein encoded by the A33R gene in the Vaccinia virus, strain Copenhagen. Protein OPG161 plays an essential role in virus morphogenesis and egress, contributing to the virulence and pathogenicity of the virus, thus offering a profound potential for virology and immunology research.

This recombinant Protein OPG161 encompasses a partial sequence, specifically the amino acid region from 57-185. It is expressed in Baculovirus and carries both N-terminal 10xHis and C-terminal Myc tags, providing an easy route for purification and detection procedures. The Recombinant Vaccinia virus A33R (OPG161) achieves a purity greater than 85%, as determined by SDS-PAGE, to ensure reliable results in your research. It is available in either liquid form or a lyophilized powder to accommodate a range of experimental setups. This product provides a unique opportunity to further understand viral pathogenesis and potentially develop effective antiviral strategies.